Literature DB >> 22293560

The neuropathic pain market.

Sarah Nightingale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22293560     DOI： 10.1038/nrd3624

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  21 in total

Review 1.  Drug repositioning: playing dirty to kill pain.

Authors:  Leandro Francisco Silva Bastos; Márcio Matos Coelho
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

Review 2.  Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain.

Authors:  Stephen D Skaper; Laura Facci; Mariella Fusco; Maria Federica Della Valle; Morena Zusso; Barbara Costa; Pietro Giusti
Journal:  Inflammopharmacology       Date:  2013-11-01       Impact factor: 4.473

3.  Dynamic modulation of inflammatory pain-related affective and sensory symptoms by optical control of amygdala metabotropic glutamate receptor 4.

Authors:  C Zussy; X Gómez-Santacana; X Rovira; D De Bundel; S Ferrazzo; D Bosch; D Asede; F Malhaire; F Acher; J Giraldo; E Valjent; I Ehrlich; F Ferraguti; J-P Pin; A Llebaria; C Goudet
Journal:  Mol Psychiatry       Date:  2016-12-20       Impact factor: 15.992

4.  New consensus multivariate models based on PLS and ANN studies of sigma-1 receptor antagonists.

Authors:  Aline A Oliveira; Célio F Lipinski; Estevão B Pereira; Kathia M Honorio; Patrícia R Oliveira; Karen C Weber; Roseli A F Romero; Alexsandro G de Sousa; Albérico B F da Silva
Journal:  J Mol Model       Date:  2017-10-02       Impact factor: 1.810

5.  A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects.

Authors:  Bogna M Ignatowska-Jankowska; Gemma L Baillie; Steven Kinsey; Molly Crowe; Sudeshna Ghosh; Robert A Owens; Imad M Damaj; Justin Poklis; Jenny L Wiley; Matteo Zanda; Chiara Zanato; Iain R Greig; Aron H Lichtman; Ruth A Ross
Journal:  Neuropsychopharmacology       Date:  2015-06-08       Impact factor: 7.853

6.  Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice.

Authors:  Bogna Ignatowska-Jankowska; Jenny L Wilkerson; Mohammed Mustafa; Rehab Abdullah; Micah Niphakis; Jenny L Wiley; Benjamin F Cravatt; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2015-03-11       Impact factor: 4.030

7.  Facilitation of MrgprD by TRP-A1 promotes neuropathic pain.

Authors:  Changming Wang; Leying Gu; Yonglan Ruan; Xiao Geng; Miao Xu; Niuniu Yang; Lei Yu; Yucui Jiang; Chan Zhu; Yan Yang; Yuan Zhou; Xiaowei Guan; Wenqin Luo; Qin Liu; Xinzhong Dong; Guang Yu; Lei Lan; Zongxiang Tang
Journal:  FASEB J       Date:  2018-08-27       Impact factor: 5.191

8.  Endocannabinoids in nervous system health and disease: the big picture in a nutshell.

Authors:  Stephen D Skaper; Vincenzo Di Marzo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

9.  An Ultrasonic Tool for Nerve Conduction Block in Diabetic Rat Models.

Authors:  Yee Fun Lee; Chou-Ching Lin; Jung-Sung Cheng; Gin-Shin Chen
Journal:  J Vis Exp       Date:  2017-10-20       Impact factor: 1.355

10.  The use of metformin is associated with decreased lumbar radiculopathy pain.

Authors:  Amber Taylor; Anton H Westveld; Magdalena Szkudlinska; Prathima Guruguri; Emil Annabi; Amol Patwardhan; Theodore J Price; Hussein N Yassine
Journal:  J Pain Res       Date:  2013-12-09       Impact factor: 3.133
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.